Filing Details

Accession Number:
0000899243-20-030508
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-05 21:08:40
Reporting Period:
2020-11-03
Accepted Time:
2020-11-05 21:08:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941388 Dr W Geoffrey Guy Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-11-03 9,732 $0.00 5,511,253 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 25,913 $0.00 5,537,166 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 15,336 $0.00 5,552,502 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 15,336 $0.00 5,567,838 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 204,552 $0.00 5,772,390 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 9,262 $0.00 5,781,652 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 16,317 $0.00 5,797,969 No 4 M Direct
Ordinary Shares Acquisiton 2020-11-03 10,704 $0.00 5,808,673 No 4 M Direct
Ordinary Shares Disposition 2020-11-03 56,388 $8.37 5,752,285 No 4 S Direct
Ordinary Shares Disposition 2020-11-03 140,040 $8.48 5,612,245 No 4 S Direct
Ordinary Shares Disposition 2020-11-03 92,724 $8.54 5,519,521 No 4 S Direct
Ordinary Shares Disposition 2020-11-03 18,000 $8.59 5,501,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2020-11-03 9,740 $0.00 9,732 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 25,913 $0.00 25,913 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 15,336 $0.00 15,336 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 15,336 $0.00 15,336 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 204,552 $0.00 204,552 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 9,262 $0.00 9,262 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 16,317 $0.00 16,317 $0.00
Ordinary Shares Stock Options Disposition 2020-11-03 10,704 $0.00 10,704 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8 2019-06-24 2025-06-24 No 4 M Direct
0 2020-02-15 2026-02-15 No 4 M Direct
0 2019-08-10 2027-08-10 No 4 M Direct
0 2020-08-10 2027-08-10 No 4 M Direct
0 2020-08-10 2027-08-10 No 4 M Direct
0 2019-02-26 2028-02-26 No 4 M Direct
0 2020-02-26 2028-02-26 No 4 M Direct
0 2020-03-01 2029-03-01 No 4 M Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 3, 2020.
  3. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2020.
  4. Represented by ADS.
  5. The price reported in Column 4 is a weighted average price per ordinary share ($100.49 per ADS). These shares were sold in multiple transactions at prices ranging from $100.00 per ADS (or $8.33 per ordinary share) to $100.98 per ADS (or $8.42 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. The price reported in Column 4 is a weighted average price per ordinary share ($101.81 per ADS). These shares were sold in multiple transactions at prices ranging from $101.00 per ADS (or $8.42 per ordinary share) to $101.99 per ADS (or $8.50 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. The price reported in Column 4 is a weighted average price per ordinary share ($102.45 per ADS). These shares were sold in multiple transactions at prices ranging from $102.00 per ADS (or $9.50 per ordinary share) to $102.99 per ADS (or $8.58 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  8. The price reported in Column 4 is a weighted average price per ordinary share ($103.08 per ADS). These shares were sold in multiple transactions at prices ranging from $103.08 per ADS (or $8.59 per ordinary share) to $103.09 per ADS (or $8.59 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.